Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

VIVANI MED.INC. NEW O.N.

U5P

Current price

1.02 EUR -0.03 EUR (-2.86%)

Last closed 1.05 EUR

Company –

ISIN US92854B1098

Sector Healthcare

Industry Biotechnology

Exchange Frankfurt Exchange

Capitalization 57 741 361 EUR

Yield for 12 month +31.61 %

10Y

15Y

U5P

21.11.2021 - 28.11.2021

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California. Address: 1350 South Loop Road, Alameda, CA, United States, 94502

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Activate

View

Activate

View

Analytics

WallStreet Target Price

–

P/E ratio

–

Dividend Yield

–

Revenue
Profit

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

EBITDA -24 709 999 EUR

Operating Margin TTM –

PE Ratio –

Return On Assets TTM -29.29 %

PEG Ratio –

Return On Equity TTM -86.1 %

Wall Street Target Price –

Revenue TTM –

Book Value 0.43 EUR

Revenue Per Share TTM

Dividend Share –

Quarterly Revenue Growth YOY –

Dividend Yield –

Gross Profit TTM –

Earnings per share -0.41 EUR

Diluted Eps TTM -0.41 EUR

Most Recent Quarter II 2024

Quarterly Earnings Growth YOY –

Profit Margin –

Dividend growth over 5 years

–

Continuous growth

–

Payout Ratio 5 years average

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Forward Annual Dividend Rate –

Ex Dividend Date –

Forward Annual Dividend Yield –

Last Split Factor –

Payout Ratio –

Last Split Date –

Dividend Date –

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Trailing PE –

Forward PE –

Enterprise Value Revenue –

Price Sales TTM –

Enterprise Value EBITDA -3.6391

Price Book MRQ 2.6542

Financials U5P

1 year

3 years

5 years

10 years

15 years

Track key metrics for each stock in one place without the hassle

Get Premium

Results	2019	Dynamics

* The data for this period has not yet been published

0.73 EUR 5.26 EUR

50 Day MA 1.07 EUR

Shares Short Prior Month –

200 Day MA 1.25 EUR

Short Ratio –

Shares Short –

Short Percent –

	All time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

VIVANI MED.INC. NEW O.N.